View in EDS

Ferroptosis in cancer toward molecular insights and clinical translation in pancreatic cancer.

Saved in:
Bibliographic Details
Title: Ferroptosis in cancer toward molecular insights and clinical translation in pancreatic cancer.
Authors: Chen Q; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China., Liu F; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China., Zhang Y; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China., Yan L; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China., Wu Y; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China., Xu D; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China., Wu P; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. wupengfei@njmu.edu.cn., Yuan H; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. yuanhao@njmu.edu.cn., Jiang K; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. jiangkuirong@njmu.edu.cn.
Source: Molecular cancer [Mol Cancer] 2026 Jan 17. Date of Electronic Publication: 2026 Jan 17.
Publication Model: Ahead of Print
Publication Type: Journal Article; Review
Language: English
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Imprint Name(s): Original Publication: [London] : BioMed Central, c2002-
Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
References: Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72.
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25:486–541.
Eagle H. Nutrition needs of mammalian cells in tissue culture. Sci (New York N Y). 1955;122:501–14.
Bannai S, Kitamura E. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J Biol Chem. 1980;255:2372–6.
Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT. Glutamate toxicity in a neuronal cell line involves Inhibition of cystine transport leading to oxidative stress. Neuron. 1989;2:1547–58.
Schubert D, Kimura H, Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci USA. 1992;89:8264–7.
Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285–96.
Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15:234–45.
Yang W.S., SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317–31.
Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA. 2016;113:E4966–4975.
Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91–8.
Kim SE, Zhang L, Ma K, Riegman M, Chen F, Ingold I, et al. Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat Nanotechnol. 2016;11:977–85.
Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688–92.
Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693–8.
Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, Müller C, Zandkarimi F, et al. GTP cyclohydrolase 1/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6:41–53.
Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586–90.
Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608:778–83.
Nakamura T, Hipp C, Santos Dias Mourão A, Borggräfe J, Aldrovandi M, Henkelmann B, et al. Phase separation of FSP1 promotes ferroptosis. Nature. 2023;619:371–7.
Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186:2748–e27642722.
Li Y, Ran Q, Duan Q, Jin J, Wang Y, Yu L, et al. 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 2024;626:411–8.
Freitas FP, Alborzinia H, Dos Santos AF, Nepachalovich P, Pedrera L, Zilka O, et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626:401–10.
Cañeque T, Baron L, Müller S, Carmona A, Colombeau L, Versini A, et al. Activation of lysosomal iron triggers ferroptosis in cancer. Nature. 2025;642:492–500.
Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770–6.
Nagata S. Apoptosis and clearance of apoptotic cells. Annu Rev Immunol. 2018;36:489–517.
Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20:175–93.
Weinlich R, Oberst A, Beere HM, Green DR. Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol. 2017;18:127–36.
Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18:100.
Tang J, Zhuang Y, Zhang Y, Hu H, Wang H, Xu H, et al. Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. J Hematol Oncol. 2025;18:77.
Liu Y, Pan R, Ouyang Y, Gu W, Xiao T, Yang H, et al. Pyroptosis in health and disease: mechanisms, regulation and clinical perspective. Signal Transduct Target Ther. 2024;9:245.
Bai Y, Pan Y, Liu X. Mechanistic insights into gasdermin-mediated pyroptosis. Nat Rev Mol Cell Biol. 2025;26:501–21.
Meng Y, Chen Q, Zhou Z, Li M. Regulated cell death in cancer: Mechanisms, crosstalk, and opportunities for therapy. Cancer Lett. 2025;635:218077.
Tang D, Kroemer G, Kang R. Targeting Cuproplasia and Cuproptosis in cancer. Nat Rev Clin Oncol. 2024;21:370–88.
Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer. 2023;22:46.
Hu J, Jiang X. When essential metal elements become culprits-Cuproptosis in focus. Cancer Cell. 2025;43:1181–5.
Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424–42.
Diao J, Jia Y, Dai E, Liu J, Kang R, Tang D, et al. Ferroptotic therapy in cancer: benefits, side effects, and risks. Mol Cancer. 2024;23:89.
Wahida A, Conrad M. Decoding ferroptosis for cancer therapy. Nat Rev Cancer. 2025;25:910–24.
Altalbawy FMA, Theab EY, Sanghvi G, Roopashree R, Kashyap A, Al-Hetty H, et al. Deciphering autophagy signaling in cancer: A paradigm shift from molecular classifications to clinical innovations. Semin Oncol. 2025;52:152397.
Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10–45.
Stoop TF, Javed AA, Oba A, Koerkamp BG, Seufferlein T, Wilmink JW, et al. Pancreatic cancer. Lancet. 2025;405:1182–202.
Mavros MN, Moris D, Karanicolas PJ, Katz MHG, O’Reilly EM, Pawlik TM. Clinical trials of systemic chemotherapy for resectable pancreatic cancer: A review. JAMA Surg. 2021;156:663–72.
Chen Q, Liu F, Yan L, Huang X, Wei J, Guo F, et al. Application of single-layer continuous duct-to-mucosa pancreaticojejunostomy in oncologic pancreaticoduodenectomy. Semin Oncol. 2025;52:152415.
Leonhardt C.S., Gustorff C., Klaiber U., Le Blanc S., Stamm T.A., Verbeke C.S., et al. Prognostic factors for early recurrence after resection of pancreatic cancer: A systematic review and Meta-Analysis. Gastroenterology. 2024;167:977–92.
Hilmi M, Delaye M, Muzzolini M, Nicolle R, Cros J, Hammel P, et al. The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy. Lancet Gastroenterol Hepatol. 2023;8:1129–42.
O’Kane GM, Lowery MA. Moving the needle on precision medicine in pancreatic cancer. J Clin Oncol. 2022;40:2693–705.
Dutt S, Hamza I, Bartnikas TB. Molecular mechanisms of iron and Heme metabolism. Annu Rev Nutr. 2022;42:311–35.
Zhang D, Duque-Jimenez J, Facchinetti F, Brixi G, Rhee K, Feng WW, et al. Transferrin receptor targeting chimeras for membrane protein degradation. Nature. 2025;638:787–95.
Hoelzgen F, Nguyen TTP, Klukin E, Boumaiza M, Srivastava AK, Kim EY, et al. Structural basis for the intracellular regulation of ferritin degradation. Nat Commun. 2024;15:3802.
Tang Z, Zhao P, Wang H, Liu Y, Bu W. Biomed Meets Fenton Chem Chem Rev. 2021;121:1981–2019.
Huang B, Wu Z, Wang X, Song X, Zhou H, Zhang H, et al. Coupled Surface-Confinement effect and pore engineering in a Single-Fe-Atom catalyst for ultrafast Fenton-like reaction with High-Valent Iron-Oxo complex oxidation. Environ Sci Technol. 2023;57:15667–79.
Yang Y, Luo M, Zhang K, Zhang J, Gao T, Connell DO, et al. Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma. Nat Commun. 2020;11:433.
Su L, Zhang J, Gomez H, Kellum JA, Peng Z. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 2023;19:401–14.
Yan B, Ai Y, Sun Q, Ma Y, Cao Y, Wang J, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell. 2021;81:355–69. e310.
Wood I, Trostchansky A, Rubbo H. Structural considerations on Lipoxygenase function, Inhibition and crosstalk with nitric oxide pathways. Biochimie. 2020;178:170–80.
Xiang P, Chen Q, Chen L, Lei J, Yuan Z, Hu H, et al. Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE(-/-)mice. Theranostics. 2023;13:4993–5016.
Zheng H, Chen H, Cai Y, Shen M, Li X, Han Y, et al. Hydrogen sulfide-mediated persulfidation regulates homocysteine metabolism and enhances ferroptosis in non-small cell lung cancer. Mol Cell. 2024;84:4016–e40304016.
Barritt SA, DuBois-Coyne SE, Dibble CC. Coenzyme A biosynthesis: mechanisms of regulation, function and disease. Nat Metab. 2024;6:1008–23.
Zhang HF, Klein Geltink RI, Parker SJ, Sorensen PH. Transsulfuration, minor player or crucial for cysteine homeostasis in cancer. Trends Cell Biol. 2022;32:800–14.
Zhao J, Li X, Ma T, Chang B, Zhang B, Fang J. Glutathione-triggered prodrugs: design strategies, potential applications, and perspectives. Med Res Rev. 2024;44:1013–54.
Kumaraswamy E, Carlson BA, Morgan F, Miyoshi K, Robinson GW, Su D, et al. Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol Cell Biol. 2003;23:1477–88.
Yoo HC, Park SJ, Nam M, Kang J, Kim K, Yeo JH, et al. A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells. Cell Metab. 2020;31:267–e283212.
Yu T, Van der Jeught K, Zhu H, Zhou Z, Sharma S, Liu S, et al. Inhibition of Glutamate-to-Glutathione flux promotes tumor antigen presentation in colorectal cancer cells. Adv Sci (Weinh). 2025;12:e2310308.
Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol. 2023;33:1077–87.
Wang Y, Hu M, Cao J, Wang F, Han JR, Wu TW, et al. ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization. Cell. 2025;188:412–e429427.
Gan B. ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity. Signal Transduct Target Ther. 2022;7:128.
Mathiowetz AJ, Olzmann JA. Lipid droplets and cellular lipid flux. Nat Cell Biol. 2024;26:331–45.
Liu N, Wu WL, Wan XR, Wang J, Huang JN, Jiang YY, et al. Regulation of FSP1 myristoylation by NADPH: A novel mechanism for ferroptosis Inhibition. Redox Biol. 2024;73:103176.
Deshwal S, Onishi M, Tatsuta T, Bartsch T, Cors E, Ried K, et al. Mitochondria regulate intracellular coenzyme Q transport and ferroptotic resistance via STARD7. Nat Cell Biol. 2023;25:246–57.
Sun WY, Tyurin VA, Mikulska-Ruminska K, Shrivastava IH, Anthonymuthu TS, Zhai YJ, et al. Phospholipase iPLA(2)β averts ferroptosis by eliminating a redox lipid death signal. Nat Chem Biol. 2021;17:465–76.
Jimenez A.J., Maiuri P., Lafaurie-Janvore J., Divoux S., Piel M., Perez F. ESCRT machinery is required for plasma membrane repair. Sci (New York N Y). 2014;343:1247136.
Pereira S, Breen DM, Naassan AE, Wang PY, Uchino H, Fantus IG, et al. In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity. Metabolism. 2015;64:315–22.
Magtanong L, Ko PJ, To M, Cao JY, Forcina GC, Tarangelo A, et al. Exogenous monounsaturated fatty acids promote a Ferroptosis-Resistant cell state. Cell Chem Biol. 2019;26:420–e432429.
Firsov AM, Franco MSF, Chistyakov DV, Goriainov SV, Sergeeva MG, Kotova EA, et al. Deuterated polyunsaturated fatty acids inhibit photoirradiation-induced lipid peroxidation in lipid bilayers. J Photochem Photobiol B. 2022;229:112425.
Xiang Z, Zhang P, Jia C, Xu R, Cao D, Xu Z, et al. Piezo1 channel exaggerates ferroptosis of nucleus pulposus cells by mediating mechanical stress-induced iron influx. Bone Res. 2024;12:20.
DeHart DN, Fang D, Heslop K, Li L, Lemasters JJ, Maldonado EN. Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells. Biochem Pharmacol. 2018;148:155–62.
Qiu B, Zandkarimi F, Bezjian CT, Reznik E, Soni RK, Gu W, et al. Phospholipids with two polyunsaturated fatty acyl Tails promote ferroptosis. Cell. 2024;187:1177–e11901118.
Li W, Han J, Huang B, Xu T, Wan Y, Luo D et al. SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis susceptibility via FSP1 acetylation. EMBO J. 2025;44:1641–62.
Gopal RK, Vantaku VR, Panda A, Reimer B, Rath S, To TL, et al. Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma. Cancer Discov. 2023;13:1904–21.
Li C, Zhang Y, Liu J, Kang R, Klionsky DJ, Tang D. Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death. Autophagy. 2021;17:948–60.
Nakamura T, Ogawa M, Kojima K, Takayanagi S, Ishihara S, Hattori K, et al. The mitochondrial Ca(2+) uptake regulator, MICU1, is involved in cold stress-induced ferroptosis. EMBO Rep. 2021;22:e51532.
Yang P, Li J, Zhang T, Ren Y, Zhang Q, Liu R, et al. Ionizing radiation-induced mitophagy promotes ferroptosis by increasing intracellular free fatty acids. Cell Death Differ. 2023;30:2432–45.
Guo Y, Zhang H, Yan C, Shen B, Zhang Y, Guo X, et al. Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction. Nat Chem Biol. 2023;19:468–77.
Zhou TJ, Zhang MM, Liu DM, Huang LL, Yu HQ, Wang Y, et al. Glutathione depletion and dihydroorotate dehydrogenase Inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer. Biomaterials. 2024;305:122447.
Song J, Zhang J, Shi Y, Gao Q, Chen H, Ding X, et al. Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis. Oncogene. 2024;43:2000–14.
Liu Z, Liu C, Fan C, Li R, Zhang S, Liu J, et al. E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer. Drug Resist Updat. 2024;77:101154.
Shi X, Xu T, Gao M, Bi Y, Wang J, Yin Y, et al. Combined exposure of Emamectin benzoate and microplastics induces tight junction disorder, immune disorder and inflammation in carp midgut via lysosome/ROS/ferroptosis pathway. Water Res. 2024;257:121660.
Gupta U, Ghosh S, Wallace CT, Shang P, Xin Y, Nair A.P., et al. Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD. Autophagy. 2023;19:92–111.
Yang L, Ye F, Liu J, Klionsky DJ, Tang D, Kang R. Extracellular SQSTM1 exacerbates acute pancreatitis by activating autophagy-dependent ferroptosis. Autophagy. 2023;19:1733–44.
He Z, Zheng D, Li F, Chen L, Wu C, Zeng Z, et al. TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4. Drug Resist Updat. 2025;78:101171.
Yang M, Chen P, Liu J, Zhu S, Kroemer G, Klionsky DJ, et al. Clockophagy is a novel selective autophagy process favoring ferroptosis. Sci Adv. 2019;5:eaaw2238.
Wu K, Yan M, Liu T, Wang Z, Duan Y, Xia Y, et al. Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function. Nat Cell Biol. 2023;25:714–25.
Zhu W, Cheng X, Xu P, Gu Y, Xu H, Xu J, et al. Radiotherapy-Driven nanoprobes targeting for visualizing tumor infiltration dynamics and inducing ferroptosis in Myeloid-Derived suppressor cells. J Am Chem Soc. 2024;146:22455–68.
Zheng H, Peng W, Liu M, Zhang S, Song X, Yang L. Ratiometric fluorescent probe for Super-Resolution imaging of lysosome HClO in ferroptosis cells. Anal Chem. 2024;96:11581–7.
Chen Y, Zhang Y, Wu C, Zhao X, Zhang H, Li C, et al. High-Throughput screening strategy and Metal-Organic Framework-Based multifunctional Controlled-Release nanomaterial for osteoarthritis therapy. ACS Nano. 2025;19:4802–19.
Nobuta H, Yang N, Ng YH, Marro SG, Sabeur K, Chavali M, et al. Oligodendrocyte death in Pelizaeus-Merzbacher disease is rescued by iron chelation. Cell Stem Cell. 2019;25:531–e541536.
Zhu S, Zhang Q, Sun X, Zeh HJ 3rd, Lotze MT, Kang R, et al. HSPA5 regulates ferroptotic cell death in cancer cells. Cancer Res. 2017;77:2064–77.
Nguyen KT, Mun SH, Yang J, Lee J, Seok OH, Kim E, et al. The MARCHF6 E3 ubiquitin ligase acts as an NADPH sensor for the regulation of ferroptosis. Nat Cell Biol. 2022;24:1239–51.
Xin S, Mueller C, Pfeiffer S, Kraft VAN, Merl-Pham J, Bao X, et al. MS4A15 drives ferroptosis resistance through calcium-restricted lipid remodeling. Cell Death Differ. 2022;29:670–86.
Li X, Lin Q, Gou F, Zhu J, Yu M, Hong Q, et al. Effects of hesperidin on mitochondrial function, mitochondria-associated Endoplasmic reticulum membranes and IP3R-MCU calcium axis in the intestine of piglets exposed to Deoxynivalenol. Food Funct. 2024;15:6459–74.
Peng XX, Zhang H, Zhang R, Li ZH, Yang ZS, Zhang J, et al. Gallium triggers ferroptosis through a synergistic mechanism. Angew Chem Int Ed Engl. 2023;62:e202307838.
Jiang J, Zhang Q, Zhang Y, Gao L, Feng Y, Sun X, et al. A high-contrast NIR excitation probe for monitoring Cu(2+) in the Endoplasmic reticulum for synergistic Cuproptosis and ferroptosis anticancer therapy. Nanoscale. 2025;17:2782–92.
Smolková K, Gotvaldová K. Fatty acid trafficking between lipid droplets and mitochondria: an emerging perspective. Int J Biol Sci. 2025;21:1863–73.
Xiong T, Chen Y, Peng Q, Lu S, Long S, Li M, et al. Lipid droplet targeting type I photosensitizer for ferroptosis via lipid peroxidation accumulation. Adv Mater. 2024;36:e2309711.
Qian Y, Ma S, Qiu R, Sun Z, Liu W, Wu F, et al. Golgi protein ACBD3 downregulation sensitizes cells to ferroptosis. Cell Biol Int. 2024;48:1559–72.
Ni J, Zhang L, Feng G, Bao W, Wang Y, Huang Y, et al. Vanillic acid restores homeostasis of intestinal epithelium in colitis through inhibiting CA9/STIM1-mediated ferroptosis. Pharmacol Res. 2024;202:107128.
Zhang Z, Zhao C, Sun L, Cheng C, Tian Q, Wu C, et al. Trappc1 intrinsically prevents ferroptosis of Naive T cells to avoid spontaneous autoinflammatory disease in mice. Eur J Immunol. 2024;54:e2350836.
Chang J, Wang Y, Kong X, Dong B, Yue T. Golgi apparatus-targeting fluorescent probe for the imaging of superoxide anion (O(2)(•-)) in living cells during ferroptosis. Anal Chim Acta. 2024;1298:342410.
Guo Y, Zhou P, Qiao L, Guan H, Gou J, Liu X. Maternal protein deficiency impairs peroxisome biogenesis and leads to oxidative stress and ferroptosis in liver of fetal growth restriction offspring. J Nutr Biochem. 2023;121:109432.
Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585:603–8.
Cui W, Liu D, Gu W, Chu B. Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis. Cell Death Differ. 2021;28:2536–51.
Hwang JS, Kim E, Lee HG, Lee WJ, Won JP, Hur J, et al. Peroxisome proliferator-activated receptor δ rescues xCT-deficient cells from ferroptosis by targeting peroxisomes. Biomed Pharmacother. 2021;143:112223.
Chen J, Wang Y, Li M, Zhu X, Liu Z, Chen Q, et al. Netrin-1 alleviates early brain injury by regulating ferroptosis via the PPARγ/Nrf2/GPX4 signaling pathway following subarachnoid hemorrhage. Transl Stroke Res. 2024;15:219–37.
Wang WJ, Ling YY, Zhong YM, Li ZY, Tan CP, Mao ZW. Ferroptosis-Enhanced cancer immunity by a Ferrocene-Appended Iridium(III) diphosphine complex. Angew Chem Int Ed Engl. 2022;61:e202115247.
Song M, Yuan J, Zhang G, Sun M, Zhang Y, Su X, et al. Mitochondrial transfer of drug-loaded artificial mitochondria for enhanced anti-Glioma therapy through synergistic apoptosis/ferroptosis/immunogenic cell death. Acta Biomater. 2025;193:514–30.
Huang T, Zhang K, Wang J, He K, Zhou X, Nie S. Quercetin alleviates Acrylamide-Induced liver injury by inhibiting Autophagy-Dependent ferroptosis. J Agric Food Chem. 2023;71:7427–39.
Dong J, Du C, Xu C, Wang Q, Wang Z, Zhu Q, et al. Verbenalin attenuates hepatic damage and mitochondrial dysfunction in alcohol-associated steatohepatitis by regulating MDMX/PPARα-mediated ferroptosis. J Ethnopharmacol. 2023;307:116227.
Tan H, Shen Z, Wang X, Shu S, Deng J, Lu L, et al. Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating Endoplasmic reticulum function in colon cancer. J Control Release. 2024;375:422–37.
Li H, Luo X, Jian Y, Lv J, Li X, Gao J, et al. An Endoplasmic reticulum-targeting hydroxyl radical fluorescent probe for imaging of ferroptosis and screening of natural protectants. Chem Sci. 2025;16:4136–43.
Wang B, Li C, He D, Ding K, Tian Q, Feng G et al. Bioconjugation and Reaction-Induced Tumor Therapy via Alkynamide-Based Thiol-Yne Click Reaction. Small. 2024;20:e2307309.
Li W, Yin S, Shen Y, Li H, Yuan L, Zhang XB. Molecular engineering of pH-Responsive NIR oxazine assemblies for evoking tumor ferroptosis via triggering lysosomal dysfunction. J Am Chem Soc. 2023;145:3736–47.
Zheng D, Li F, Wang S, Liu PS, Xie X. High-content image screening to identify chemical modulators for peroxisome and ferroptosis. Cell Mol Biol Lett. 2024;29:26.
Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31–46.
Ye Z, Zhuo Q, Hu Q, Xu X, Mengqi L, Zhang Z, et al. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. Redox Biol. 2021;38:101807.
Zhao Z, Wu Y, Liang X, Liu J, Luo Y, Zhang Y, et al. Sonodynamic therapy of NRP2 monoclonal Antibody-Guided MOFs@COF targeted disruption of mitochondrial and Endoplasmic reticulum homeostasis to induce Autophagy-Dependent ferroptosis. Adv Sci (Weinh). 2023;10:e2303872.
Wang M, Cao G, Zhou J, Cai J, Ma X, Liu Z, et al. Ligustrazine-Derived Chalcones-Modified Platinum(IV) complexes intervene in cisplatin resistance in pancreatic cancer through ferroptosis and apoptosis. J Med Chem. 2023;66:13587–606.
Ding Y, Bai Y, Chen T, Chen S, Feng W, Ma S, et al. Disruption of the sorcin–PAX5 protein–protein interaction induces ferroptosis by promoting the FBXL12-mediated ubiquitination of ALDH1A1 in pancreatic cancer. J Hematol Oncol. 2025;18:27.
Daher B, Meira W, Durivault J, Gotorbe C, Pouyssegur J, Vucetic M. Genetic disruption of the γ-Glutamylcysteine ligase in PDAC cells induces Ferroptosis-Independent cell death in vitro without affecting in vivo tumor growth. Cancers (Basel). 2022;14:3154.
Chen HD, Ye Z, Hu HF, Fan GX, Hu YH, Li Z, et al. SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer. Acta Pharmacol Sin. 2024;45:844–56.
Dai E, Han L, Liu J, Xie Y, Zeh HJ, Kang R, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway. Nat Commun. 2020;11:6339.
Liu X, Guo X, Li H, Chen J, Han H. Effects of KAI gene expression on ferroptosis in pancreatic cancer cells. Mol Med Rep. 2021;23:163.
Hu Q, Jiang C, Qin Y, Li B, Wang J, Wang T, et al. Pentose phosphate recycling driven by Gli1 contributes to chemotherapy resistance in cancer cells. Cancer Lett. 2025;618:217633.
Zhu Y, Fang S, Fan B, Xu K, Xu L, Wang L, et al. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer. Theranostics. 2024;14:1683–700.
Zheng Y, Zhu L, Qin ZY, Guo Y, Wang S, Xue M, et al. Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression. Cell Rep. 2023;42:112666.
Schneider C, Hilbert J, Genevaux F, Höfer S, Krauß L, Schicktanz F, et al. A novel AMPK inhibitor sensitizes pancreatic cancer cells to ferroptosis induction. Adv Sci (Weinh). 2024;11:e2307695.
Daher B, Parks SK, Durivault J, Cormerais Y, Baidarjad H, Tambutte E, et al. Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, Growth, Survival, and tumor formation via nutrient and oxidative stresses. Cancer Res. 2019;79:3877–90.
Zhang Y, Huang Z, Cheng J, Pan H, Lin T, Shen X, et al. Platelet-Vesicles-Encapsulated RSL-3 enable Anti-Angiogenesis and induce ferroptosis to inhibit pancreatic cancer progress. Front Endocrinol (Lausanne). 2022;13:865655.
Xue Q, Yan D, Chen X, Li X, Kang R, Klionsky DJ, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy. 2023;19:1982–96.
Pan Z, Van den Bossche JL, Rodriguez-Aznar E, Janssen P, Lara O, Ates G, et al. Pancreatic acinar cell fate relies on system x(C)(-) to prevent ferroptosis during stress. Cell Death Dis. 2023;14:536.
Qi R, Bai Y, Li K, Liu N, Xu Y, Dal E, et al. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting MiRNAs. Drug Resist Updat. 2023;68:100960.
Feng L, Chen L, Wang W, Wei Q, Chen M, Jiang X, et al. PRMT6-mediated ADMA promotes p62 phase separation to form a negative feedback loop in ferroptosis. Theranostics. 2024;14:4090–106.
Chen Y, Xu W, Jin H, Zhang M, Liu S, Liu Y, et al. Nutritional Glutamine-Modified Iron-Delivery system with enhanced endocytosis for ferroptosis therapy of pancreatic tumors. ACS Nano. 2024;18:31846–68.
Che B, Du Y, Yuan R, Xiao H, Zhang W, Shao J, et al. SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. Oncogene. 2023;42:3260–73.
Villani A, Fontana A, Panebianco C, Ferro C, Copetti M, Pavlovic R, et al. A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer. Gut Microbes. 2024;16:2375483.
Dai X, Zhang J, Bao X, Guo Y, Jin Y, Yang C, et al. Induction of tumor Ferroptosis-Dependent immunity via an injectable attractive Pickering emulsion gel. Adv Mater. 2023;35:e2303542.
Dai E, Han L, Liu J, Xie Y, Kroemer G, Klionsky DJ, et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 2020;16:2069–83.
Wang X, Li Y, Li Z, Lin S, Wang H, Sun J, et al. Mitochondrial calcium uniporter drives metastasis and confers a targetable cystine dependency in pancreatic cancer. Cancer Res. 2022;82:2254–68.
Liu J, Liu Y, Wang Y, Li C, Xie Y, Klionsky DJ, et al. TMEM164 is a new determinant of autophagy-dependent ferroptosis. Autophagy. 2023;19:945–56.
Cao Y, Wang X, Liu Y, Liu P, Qin J, Zhu Y, et al. BHLHE40 inhibits ferroptosis in pancreatic cancer cells via upregulating SREBF1. Adv Sci (Weinh). 2024;11:e2306298.
Helms EJ, Berry MW, Chaw RC, DuFort CC, Sun D, Onate MK, et al. Mesenchymal lineage heterogeneity underlies nonredundant functions of pancreatic Cancer-Associated fibroblasts. Cancer Discov. 2022;12:484–501.
Mucciolo G, Araos Henríquez J, Jihad M, Pinto Teles S, Manansala JS, Li W, et al. EGFR-activated myofibroblasts promote metastasis of pancreatic cancer. Cancer Cell. 2024;42:101–e118111.
Niu N, Shen X, Wang Z, Chen Y, Weng Y, Yu F, et al. Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Cancer Cell. 2024;42:869–e884869.
Wehrli M, Guinn S, Birocchi F, Kuo A, Sun Y, Larson RC, et al. Mesothelin CAR T cells secreting Anti-FAP/Anti-CD3 molecules efficiently target pancreatic adenocarcinoma and its stroma. Clin Cancer Res. 2024;30:1859–77.
Tao M, Liu W, Chen J, Liu R, Zou J, Yu B, et al. Transcriptome landscape of Cancer-Associated fibroblasts in human PDAC. Adv Sci (Weinh). 2025;12:e2415196.
Huang A, Li Q, Shi X, Gao J, Ma Y, Ding J, et al. An iron-containing nanomedicine for inducing deep tumor penetration and synergistic ferroptosis in enhanced pancreatic cancer therapy. Mater Today Bio. 2024;27:101132.
Abu-Serie MM, Gutiérrez-García AK, Enman M, Vaish U, Fatima H, Dudeja V. Ferroptosis- and stemness inhibition-mediated therapeutic potency of ferrous oxide nanoparticles-diethyldithiocarbamate using a co-spheroid 3D model of pancreatic cancer. J Gastroenterol. 2025;60:641–57.
Guirguis DA, Hasan F, Morris N, Alabd A, Tawfik PMS, Pramanik K, et al. Tumor tough, therapy smarter: rethinking CAR-T for pancreatic cancer. Semin Oncol. 2025;52:152411.
Zhou H, Wang W, Cai Z, Jia ZY, Li YY, He W, et al. Injectable hybrid hydrogels enable enhanced combination chemotherapy and roused anti-tumor immunity in the synergistic treatment of pancreatic ductal adenocarcinoma. J Nanobiotechnol. 2024;22:353.
Li G, Liao C, Chen J, Wang Z, Zhu S, Lai J, et al. Targeting the MCP-GPX4/HMGB1 axis for effectively triggering Immunogenic ferroptosis in pancreatic ductal adenocarcinoma. Adv Sci (Weinh). 2024;11:e2308208.
Zhang H, Zhuo Y, Li D, Zhang L, Gao Q, Yang L, et al. Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity. Eur J Pharmacol. 2022;926:175028.
Ruze R, Chen Y, Song J, Xu R, Yin X, Xu Q, et al. Enhanced cytokine signaling and ferroptosis defense interplay initiates obesity-associated pancreatic ductal adenocarcinoma. Cancer Lett. 2024;601:217162.
Mao W, Jiang Q, Feng Y, Peng C, Peng H, Li X, et al. TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of Anti-PD-1 immunotherapy. Cell Death Dis. 2025;16:240.
Li J, Liu J, Zhou Z, Wu R, Chen X, Yu C, et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023;15:eadg3049.
Lin H, Zhu S, Chen Y, Lu J, Xie C, Liao C, et al. Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. Drug Resist Updat. 2025;81:101240.
Shi Y, Wang Y, Dong H, Niu K, Zhang W, Feng K, et al. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis. 2023;28:1423–35.
Yin H, Chen Q, Gao S, Shoucair S, Xie Y, Habib JR, et al. The crosstalk with CXCL10-Rich Tumor-Associated mast cells fuels pancreatic cancer progression and immune escape. Adv Sci (Weinh). 2025;12:e2417724.
Qiao C, Wang L, Huang C, Jia Q, Bao W, Guo P, et al. Engineered bacteria manipulate cysteine metabolism to boost Ferroptosis-Based pancreatic ductal adenocarcinoma therapy. Adv Mater. 2025;37:e2412982.
Zhang S, Huang J, Lan Z, Xiao Y, Liao Y, Basnet S, et al. CPEB1 controls NRF2 proteostasis and ferroptosis susceptibility in pancreatic cancer. Int J Biol Sci. 2024;20:3156–72.
Liu B, Chen Z, Li Z, Zhao X, Zhang W, Zhang A, et al. Hsp90α promotes chemoresistance in pancreatic cancer by regulating Keap1-Nrf2 axis and inhibiting ferroptosis. Acta Biochim Biophys Sin. 2024;57:295–309.
Zhang H, Ma T, Wen X, Jiang J, Chen J, Jiang J, et al. SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis. Cancer Lett. 2025;623:217726.
Shen X, Chen Y, Tang Y, Lu P, Liu M, Mao T, et al. Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis. Cell Rep Med. 2025;6:101928.
Xiao Q, Lan Z, Zhang S, Ren H, Wang S, Wang P, et al. Overexpression of ZNF488 supports pancreatic cancer cell proliferation and tumorigenesis through Inhibition of ferroptosis via regulating SCD1-mediated unsaturated fatty acid metabolism. Biol Direct. 2023;18:77.
Wang X, Liu M, Chu Y, Liu Y, Cao X, Zhang H, et al. O-GlcNAcylation of ZEB1 facilitated mesenchymal pancreatic cancer cell ferroptosis. Int J Biol Sci. 2022;18:4135–50.
Hu Y, Hu Y, Zhang S, Guo Y, Wang F, Du Y, et al. Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer. Cancer Lett. 2025;614:217523.
Mukherjee D, Chakraborty S, Bercz L, D’Alesio L, Wedig J, Torok MA et al. Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression. iScience. 2023;26:107408.
Chen J, Yue L, Pan Y, Jiang B, Wan J, Lin H et al. Novel Cyano-Artemisinin dimer ZQJ29 targets PARP1 to induce ferroptosis in pancreatic cancer treatment. Adv Sci (Weinh). 2025;12:e01935.
Xu C, Lin W, Zhang Q, Ma Y, Wang X, Guo A, et al. MGST1 facilitates novel KRAS(G12D) inhibitor resistance in KRAS(G12D)-mutated pancreatic ductal adenocarcinoma by inhibiting ferroptosis. Mol Med. 2024;30:199.
Luo Z, Zheng Q, Ye S, Li Y, Chen J, Fan C, et al. HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells. Cell Death Dis. 2024;15:220.
Zhao H, Huang Q, Liu YA, Wu W. Oncogenic KRAS promotes ferroptosis in pancreatic cancer through regulation of the Fosl1-Tfrc axis. Pancreas. 2025;54:e235–45.
Zhang Z, Xu H, He J, Hu Q, Liu Y, Xu Z, et al. Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells. Cell Death Dis. 2025;16:28.
Zhou L, Yang C, Zhong W, Wang Q, Zhang D, Zhang J, et al. Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells. Biochem Pharmacol. 2021;193:114813.
Rademaker G, Boumahd Y, Peiffer R, Anania S, Wissocq T, Liégeois M, et al. Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biol. 2022;53:102324.
Kremer DM, Nelson BS, Lin L, Yarosz EL, Halbrook CJ, Kerk SA, et al. GOT1 Inhibition promotes pancreatic cancer cell death by ferroptosis. Nat Commun. 2021;12:4860.
Jia Y, Ye Z, Wang X, Deng Y, Wang C, Zhang Z, et al. NCOA6 knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine. Acta biochimica et biophysica Sinica. 2025;57:1260–69.
Rademaker G, Hernandez GA, Seo Y, Dahal S, Miller-Phillips L, Li AL et al. PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Nature. 2025;643:1381–90.
Su D, Ding C, Wang R, Qiu J, Liu Y, Tao J, et al. E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation. Free Radic Biol Med. 2024;221:136–54.
Seo R, de Guzman ACV, Park S, Lee JY, Kang SJ. Cancer-intrinsic Cxcl5 orchestrates a global metabolic reprogramming for resistance to oxidative cell death in 3D. Cell Death Differ. 2025;32:1200–13.
Liu Y, Wang Y, Lin Z, Kang R, Tang D, Liu J. SLC25A22 as a key mitochondrial transporter against ferroptosis by producing glutathione and monounsaturated fatty acids. Antioxid Redox Signal. 2023;39:166–85.
Hsu CY, Almajidi YQ, Al-Hakeem MA, Alshahrani MY, Nabil W, Jayakumar SS, et al. Deregulated cell cycle control: the interplay between non-coding RNAs and cyclin-dependent kinases in tumorigenesis. Semin Oncol. 2025;52:152395.
Zhang L, Yang L, Du K. Exosomal HSPB1, interacting with FUS protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450. J Cell Mol Med. 2024;28:e18209.
Gao H, Xie R, Huang R, Wang C, Wang Y, Wang D et al. CIRBP Regulates Pancreatic Cancer Cell Ferroptosis and Growth by Directly Binding to p53. J Immunol Res. 2022;2022:2527210.
Wu T, Qian TY, Lin RJ, Jin DD, Xu XB, Huang MX, et al. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis. J Gastrointest Oncol. 2022;13:2553–64.
Wang S, Chen J, Li P, Chen Y. LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex. Cell Death Dis. 2023;14:767.
Ma H, Chen X, Mo S, Zhang Y, Mao X, Chen J, et al. Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma. Cell Death Differ. 2023;30:1988–2004.
Zhu L, Wang X, Tian T, Chen Y, Du W, Wei W, et al. A Λ-Ir(iii)-phenylquinazolinone complex enhances ferroptosis by selectively inhibiting metallothionein-1. Chem Sci. 2024;15:10499–507.
Noè R, Inglese N, Romani P, Serafini T, Paoli C, Calciolari B, et al. Organic selenium induces ferroptosis in pancreatic cancer cells. Redox Biol. 2023;68:102962.
Huang C, Santofimia-Castaño P, Liu X, Xia Y, Peng L, Gotorbe C, et al. NUPR1 inhibitor ZZW-115 induces ferroptosis in a mitochondria-dependent manner. Cell Death Discovery. 2021;7:269.
Zhang G, Li N, Qi Y, Zhao Q, Zhan J, Yu D. Synergistic ferroptosis-gemcitabine chemotherapy of the gemcitabine loaded carbonaceous nanozymes to enhance the treatment and magnetic resonance imaging monitoring of pancreatic cancer. Acta Biomater. 2022;142:284–97.
Gou Y, Chen M, Li S, Deng J, Li J, Fang G, et al. Dithiocarbazate-Copper complexes for bioimaging and treatment of pancreatic cancer. J Med Chem. 2021;64:5485–99.
Lomphithak T, Sae-Fung A, Sprio S, Tampieri A, Jitkaew S, Fadeel B. Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles. Nanomedicine. 2024;55:102714.
Xu M, Zhong W, Yang C, Liu M, Yuan X, Lu T, et al. Tiliroside disrupted iron homeostasis and induced ferroptosis via directly targeting calpain-2 in pancreatic cancer cells. Phytomedicine. 2024;127:155392.
Kaftan G, Erdoğan MA, El-Shazly M, Lu MC, Shih SP, Lin HY, et al. Heteronemin promotes iron-dependent cell death in pancreatic cancer. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:1865–74.
Li J, Lama R, Galster SL, Inigo JR, Wu J, Chandra D et al. Small-Molecule MMRi62 induces ferroptosis and inhibits metastasis in pancreatic cancer via degradation of ferritin heavy chain and mutant p53. Mol Cancer Ther. 2022;21:535–45.
Zerbato B, Gobbi M, Ludwig T, Brancato V, Pessina A, Brambilla L, et al. PGM3 Inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the unfolded protein response. Front Oncol. 2023;13:1125855.
Tao P, Jiang Y, Wang H, Gao G. CYP2J2-produced epoxyeicosatrienoic acids contribute to the ferroptosis resistance of pancreatic ductal adenocarcinoma in a PPARγ-dependent manner. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46:932–41.
Li BR, Wang T, Hu HF, Wu D, Zhou CJ, Ji SR, et al. Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity in pancreatic ductal adenocarcinoma. Acta Pharmacol Sin. 2025;46:1742–56.
Huang Z, Li M, Gu B, Chen J, Liu S, Tan P, et al. Ferroptosis-related LINC02535/has-miR-30c-5p/EIF2S1 axis as a novel prognostic biomarker involved in immune infiltration and progression of PDAC. Cell Signal. 2024;123:111338.
Xie B, Wu P, Liu H, Yang X, Huang L. Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p/STAT1. J Transl Med. 2025;23:165.
Yang Y, Gu H, Zhang K, Guo Z, Wang X, Wei Q, et al. Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer. BMC Cancer. 2023;23:789.
Wei W, Lu Y, Hu Q, Yin J, Wang Y, Zhang H, et al. Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway. Cell Oncol (Dordr). 2024;47:321–41.
Fan X, Dai Y, Mo C, Li H, Luan X, Wang B, et al. TRIM21 promotes tumor growth and gemcitabine resistance in pancreatic cancer by inhibiting EPHX1-Mediated arachidonic acid metabolism. Adv Sci (Weinh). 2025;12:e2413674.
Müller F, Lim JKM, Bebber CM, Seidel E, Tishina S, Dahlhaus A, et al. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death Differ. 2023;30:442–56.
Yu T, Tan H, Liu C, Nie W, Wang Y, Zhou K, et al. Integratively genomic analysis reveals the prognostic and immunological characteristics of pyroptosis and ferroptosis in pancreatic cancer for precision immunotherapy. Front Cell Dev Biology. 2022;10:826879.
Du J, Wang X, Li Y, Ren X, Zhou Y, Hu W, et al. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Cell Death Dis. 2021;12:705.
Yuan LQ, Wang C, Lu DF, Zhao XD, Tan LH, Chen X. Induction of apoptosis and ferroptosis by a tumor suppressing magnetic field through ROS-mediated DNA damage. Aging. 2020;12:3662–81.
Reyngold M, Schoenfeld JD, O’Reilly EM, Varghese AM, White C, Zinovoy M, et al. Nonoperative management of technically resectable pancreatic cancer with ablative radiation therapy. JAMA Oncol. 2025;11:609–16.
Tang Z, Li J, Peng L, Xu F, Tan Y, He X, et al. Novel covalent probe selectively targeting glutathione peroxidase 4 in vivo: potential applications in pancreatic cancer therapy. J Med Chem. 2024;67:1872–87.
Antoszczak M, Müller S, Cañeque T, Colombeau L, Dusetti N, Santofimia-Castaño P, et al. Iron-Sensitive prodrugs that trigger active ferroptosis in Drug-Tolerant pancreatic cancer cells. J Am Chem Soc. 2022;144:11536–45.
Wang K, Zhang Z, Wang M, Cao X, Qi J, Wang D, et al. Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells. Drug Des Devel Ther. 2019;13:2135–44.
Liu X, Peng X, Cen S, Yang C, Ma Z, Shi X. Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. Front Pharmacol. 2023;14:1129662.
Xie Y, Song X, Sun X, Huang J, Zhong M, Lotze MT, et al. Identification of Baicalein as a ferroptosis inhibitor by natural product library screening. Biochem Biophys Res Commun. 2016;473:775–80.
Su W, Gao W, Zhang R, Wang Q, Li L, Bu Q, et al. TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling. JHEP Rep. 2023;5:100695.
Liang X, Tian R, Li T, Wang H, Qin Y, Qian M, et al. Integrative insights into the role of CAV1 in ketogenic diet and ferroptosis in pancreatic cancer. Cell Death Discovery. 2025;11:139.
Yang L, TeSlaa T, Ng S, Nofal M, Wang L, Lan T, et al. Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth. Med. 2022;3:119–36.
Ferrer M, Mourikis N, Davidson EE, Kleeman SO, Zaccaria M, Habel J, et al. Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia. Cell Metab. 2023;35:1147–e11621147.
Tempero MA, Pelzer U, O’Reilly EM, Winter J, Oh DY, Li CP, Trial, et al. J Clin Oncol. 2023;41:2007–19.
Chen M, Tong X, Sun Y, Dong C, Li C, Wang C, et al. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy. Biomaterials. 2024;309:122574.
Tao W, Wang N, Ruan J, Cheng X, Fan L, Zhang P, et al. Enhanced ROS-Boosted phototherapy against pancreatic cancer via Nrf2-Mediated Stress-Defense pathway suppression and ferroptosis induction. ACS Appl Mater Interfaces. 2022;14:6404–16.
Li Z, Duan J, Liu Z, Li W, Mai Y, Fu H, et al. A triple-mode strategy on JQ1-loaded nanoplatform for superior antitumor therapy in pancreatic cancer. Mater Today Bio. 2025;32:101696.
Zhou C, Zhao Y, Yang M, Yin W, Li Y, Xiao Y, et al. Diselenide-Containing polymer based on new antitumor mechanism as efficient GSH depletion agent for ferroptosis therapy. Adv Healthc Mater. 2024;13:e2303896.
de Laat V, Topal H, Spotbeen X, Talebi A, Dehairs J, Idkowiak J, et al. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nat Commun. 2024;15:8540.
Xue B, Yan L, Ye M, Gu D, Qian J, He N, et al. PROTAC-Surufatinib suppresses pancreatic neuroendocrine neoplasms progression by inducing ferroptosis through inhibiting WNT/β-catenin pathway mediated by HMOX1. Int J Biol Sci. 2025;21:2476–92.
Jiang C, Li X, Wan S, Ji S, Wang Q, Hu S et al. Copper-Doped Polydopamine Nanoparticles-Mediated GSH/GPX4-Depleted Ferroptosis and Cuproptosis Sensitizes Lung Tumor to Checkpoint Blockade Immunotherapy. Small. 2025;21:e2503208.
Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K et al. Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. Cell. 2018;172:409–22.e421.
Mishima E, Nakamura T, Doll S, Proneth B, Fedorova M, Pratt DA et al. Recommendations for robust and reproducible research on ferroptosis. Nat Rev Mol Cell Biol. 2025;26:615–30.
Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Sci (New York N Y). 2020;368:85–9.
Wu Y, Zhang C, Huang J, Chen Q, Zhang Y, Liu F, et al. Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance. Semin Oncol. 2025;52:152338.
Chung CH, Lin CY, Chen CY, Hsueh CW, Chang YW, Wang CC, et al. Ferroptosis signature shapes the immune profiles to enhance the response to immune checkpoint inhibitors in head and neck cancer. Adv Sci (Weinh). 2023;10:e2204514.
Feng Z, Chen P, Li K, Lou J, Wu Y, Li T, et al. A novel Ferroptosis-Related gene signature predicts recurrence in patients with pancreatic ductal adenocarcinoma. Front Mol Biosci. 2021;8:650264.
Tang R, Hua J, Xu J, Liang C, Meng Q, Liu J, et al. The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer. Ann Transl Med. 2020;8:1347.
Yan T, Wang L. Discovering ferroptosis-associated tumor antigens and ferroptosis subtypes in pancreatic adenocarcinoma to facilitate mRNA vaccine development. Heliyon. 2024;10:e27194.
Cao PHA, Dominic A, Lujan FE, Senthilkumar S, Bhattacharya PK, Frigo DE, et al. Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers. Nat Rev Urol. 2024;21:615–37.
Qin J, Wang J, Bian Y, Shao C. D-A-D type based NIR fluorescence probe for monitoring the cysteine levels in pancreatic cancer cell during ferroptosis. Bioorg Chem. 2024;146:107260.
Song W, Zhang W, Yue L, Lin W. Revealing the effects of Endoplasmic reticulum stress on ferroptosis by Two-Channel Real-Time imaging of pH and viscosity. Anal Chem. 2022;94:6557–65.
Li L, Zhang Z, Zhou L, Ge H, Zhao Y, Gong Y, et al. NIR Fluorescent/Photoacoustic bimodal imaging of ferroptosis in pancreatic cancer using Biothiols-Activable probes. Anal Chem. 2024;96:7248–56.
Fan Q, Xiong W, Zhou H, Yang J, Feng J, Li Z, et al. An AND logic gate for Magnetic-Resonance-Imaging-Guided ferroptosis therapy of tumors. Adv Mater. 2023;35:e2305932.
McCormick PN, Greenwood HE, Glaser M, Maddocks ODK, Gendron T, Sander K, et al. Assessment of tumor redox status through (S)-4-(3-[(18)F]fluoropropyl)-L-Glutamic acid PET imaging of system x(c) (-) activity. Cancer Res. 2019;79:853–63.
Chen Q, Yuan H, Bronze MS, Li M. Targeting lactylation and the STAT3/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 2025;135:e191422.
Grant Information: 82503791 National Natural Science Foundation of China; ZDXK202222 Jiangsu Province Capability Improvement Project through Science, Technology and Education
Contributed Indexing: Keywords: Cancer metabolism; Ferroptosis; Molecular mechanism; Regulated cell death; Therapeutic significance; Translational medicine
Entry Date(s): Date Created: 20260117 Latest Revision: 20260117
Update Code: 20260118
DOI: 10.1186/s12943-025-02567-5
PMID: 41547783
Database: MEDLINE
Description
Abstract:Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
ISSN:1476-4598
DOI:10.1186/s12943-025-02567-5